| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/13/2001 | WO2001066153A1 Fluorescent membrane intercalating probes and methods for their use |
| 09/13/2001 | WO2001066098A2 Therapeutic uses of ppar mediators |
| 09/13/2001 | CA2402315A1 Therapeutic uses of ppar mediators |
| 09/12/2001 | EP1131321A2 Indole derivatives and their use as serotonin receptor ligands |
| 09/12/2001 | EP1131312A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 09/12/2001 | EP1131295A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 09/12/2001 | EP1131294A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 09/12/2001 | EP1131293A1 1-aminoethylquinoline derivatives for treating urinary incontinence |
| 09/12/2001 | EP0794945B1 Iminooxybenzylcrotonic acid esters, process for their preparation and use thereof |
| 09/12/2001 | EP0682514B1 Use of topical anesthetics for the manufacture of a medicament for the treatment of bronchial asthma |
| 09/11/2001 | US6288234 Fluorinated heterocyclic amido amine compounds as drugs |
| 09/11/2001 | US6288123 Therapeutic guanidines |
| 09/11/2001 | US6288120 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 09/11/2001 | US6288086 N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 09/11/2001 | US6288082 Compounds such as 6,7-diethoxy-4-(indan-5-ylamino) -quinoline-3-carbonitrile used as antineoplastic agents and in the treatment of polycycstic kidney disease |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/07/2001 | WO2001064676A2 INHIBITORS OF p38-α KINASE |
| 09/07/2001 | WO2001064660A1 Novel quinoline ligands and metal complexes for diagnosis and therapy |
| 09/07/2001 | WO2001064646A2 Hydrazones and analogs as cholesterol lowering agents |
| 09/07/2001 | WO2001064645A2 Derivatives of quinoline as alpha-2 antagonists |
| 09/07/2001 | WO2001064606A1 Method of continuously and selectively separating clathrate and apparatus therefor |
| 09/07/2001 | WO2001055111A8 Biaryl compounds, their preparation and their use in therapy |
| 09/07/2001 | CA2400657A1 Derivatives of quinoline as alpha-2 antagonists |
| 09/06/2001 | US20010020097 Treatment of Alzheimer's disease |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/05/2001 | EP1129712A1 Quinolinone derivative preparations and process for producing the same |
| 09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 09/05/2001 | EP1129071A1 Phenyl-substituted cyclic enaminones |
| 09/05/2001 | EP0959888B1 Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease |
| 09/05/2001 | CN1311785A Tetrahydroquinoline derivatives as glycine antagonists |
| 09/05/2001 | CN1311778A Fused-heterocycle dicarboxylic diamide derivatives of salts thereof, herbicides and usage thereof |
| 09/05/2001 | CN1311773A Neuropeptide Y5 receptor antagonists |
| 09/05/2001 | CN1311178A Continuous selection wraping separation method and equipment therefor |
| 09/04/2001 | US6284777 Carbohydrazide protease inhibitors |
| 09/04/2001 | US6284764 Antiproliferative agent |
| 08/30/2001 | WO2001062734A1 Process for producing quinolonecarboxylic acids and intermediates thereof |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062708A1 Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 08/30/2001 | WO2001012606A3 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2400819A1 Method for producing quinolonecarboxylic acids and intermediates thereof |
| 08/29/2001 | EP1127573A1 Compostitions and methods for treating osteoporosis |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/29/2001 | CN1310711A Process for the preparation of quinoline derivative and intermediate therefor |
| 08/29/2001 | CN1310709A N.N-substituted cyclic amine derivatives |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310621A Substituted anilide compounds and methods |
| 08/29/2001 | CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use |
| 08/29/2001 | CN1070173C Benzoylaguanidine derivatives using as medicine |
| 08/28/2001 | US6281216 2-aminoquinoline derivatives having d4-agonistic activity |
| 08/28/2001 | US6281215 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/23/2001 | WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001060800A1 Processes for preparing quinoline derivatives and intermediates thereof |
| 08/23/2001 | WO2001060797A1 Phenyl-substituted heterocyclic enaminones |
| 08/23/2001 | DE10007286A1 New phenyl-substituted heterocyclic enaminone and enaminethione derivatives useful as herbicides and pesticides, especially insecticides, acaricides, nematocides and fungicides |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | CN1309641A Quinoline derivs. |
| 08/22/2001 | CN1309640A Quinoline derivs. |
| 08/22/2001 | CN1309639A Pharmaceutical compositions comprising 2-quinolones |
| 08/21/2001 | US6278013 Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives |
| 08/21/2001 | US6277862 Quinoline derivatives |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | US6277841 Quinoline ligands and metal complexes for diagnosis and therapy |
| 08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
| 08/16/2001 | WO2001058892A1 Tyrosine derivatives with anti-leukotriene activity |
| 08/16/2001 | WO2001058889A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 08/16/2001 | WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient |
| 08/16/2001 | WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001058427A1 Particulate composition, method for producing said composition and use of the same |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | US20010014740 Method of producing heterocyclic derivatives |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP0828715B1 N-oxides as antibacterial agents |
| 08/16/2001 | EP0796248B1 Carbostyril derivatives as antithrombotic agents |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1069643C Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057017A1 Sulfate salt of quinolonecarboxylic acid derivative and use thereof |
| 08/09/2001 | WO2001056607A1 Integrin expression inhibitors |
| 08/09/2001 | WO2001056560A1 Substituted amino acids as neutral sphingomyelinase inhibitors |
| 08/09/2001 | WO2001056358A2 Enhanced propertied pesticides |
| 08/09/2001 | WO2000059878A3 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF |
| 08/09/2001 | US20010012895 Therapy for hair loss in mammals; drug resistance; nervous system disorders |
| 08/09/2001 | DE10005280A1 Partikuläre Zusammensetzung, Verfahren zu ihrer Herstellung und deren Verwendung Particulate composition, process for their preparation and their use |
| 08/09/2001 | CA2399792A1 Substituted amino acids as neutral sphingomyelinase inhibitors |